Amir Hossein Heydari, Mojtaba Fathi, Sophia Heydari, & Mohammad Esmaeil Heidari. (2022). Advanced Glycation End Product Blocker Drugs Have a Great Potential to Prevent Diabetic Cardiomyopathy in an Animal Model of Diabetes Mellitus Type-2. Hindawi-Wiley.
Chicago Style (17th ed.) CitationAmir Hossein Heydari, Mojtaba Fathi, Sophia Heydari, and Mohammad Esmaeil Heidari. Advanced Glycation End Product Blocker Drugs Have a Great Potential to Prevent Diabetic Cardiomyopathy in an Animal Model of Diabetes Mellitus Type-2. Hindawi-Wiley, 2022.
MLA (9th ed.) CitationAmir Hossein Heydari, et al. Advanced Glycation End Product Blocker Drugs Have a Great Potential to Prevent Diabetic Cardiomyopathy in an Animal Model of Diabetes Mellitus Type-2. Hindawi-Wiley, 2022.
Warning: These citations may not always be 100% accurate.